Evaluation of IHC results in whole sections by comparison with TMA results: number of concordant cases/number of evaluable cases
| . | Concordant results between whole sections and TMA cores (%) . |
|---|---|
| CD20 | 32/39 (82.5) |
| CD30 | 38/38 (100) |
| CD15 | 36/39 (92.3) |
| BCL2 | 35/39 (89.8) |
| BCL6 | 37/41 (90.2) |
| P53 | 39/39 (100) |
| P16 | 30/37 (81.8) |
| PTEN | 35/35 (100) |
| LMP | 37/37 (100) |
| EBER | 41/41 (100) |
| Overall concordance | 93.5% |
| . | Concordant results between whole sections and TMA cores (%) . |
|---|---|
| CD20 | 32/39 (82.5) |
| CD30 | 38/38 (100) |
| CD15 | 36/39 (92.3) |
| BCL2 | 35/39 (89.8) |
| BCL6 | 37/41 (90.2) |
| P53 | 39/39 (100) |
| P16 | 30/37 (81.8) |
| PTEN | 35/35 (100) |
| LMP | 37/37 (100) |
| EBER | 41/41 (100) |
| Overall concordance | 93.5% |
Percentage concordance is shown in brackets. All the cases correspond to classical HL samples.